Targeting TNFR2: A Novel Breakthrough in the Treatment of Cancer
Open Access
- 14 April 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 12, 862154
Abstract
Tumor necrosis factor (TNF) receptor type II (TNFR2) is expressed in various tumor cells and some immune cells, such as regulatory T cells and myeloid-derived suppressing cells. TNFR2 contributes a lot to the tumor microenvironment. For example, it directly promotes the occurrence and growth of some tumor cells, activates immunosuppressive cells, and supports immune escape. Existing studies have proved the importance of TNFR2 in cancer treatment. Here, we reviewed the activation mechanism of TNFR2 and its role in signal transduction in the tumor microenvironment. We summarized the expression and function of TNFR2 within different immune cells and the potential opportunities and challenges of targeting TNFR2 in immunotherapy. Finally, the advantages and limitations of TNFR2 to treat tumor-related diseases are discussed, and the problems that may be encountered in the clinical development and application of targeted anti-TNFR2 agonists and inhibitors are analyzed.Keywords
This publication has 130 references indexed in Scilit:
- Homogeneous Expansion of Human T-Regulatory Cells Via Tumor Necrosis Factor Receptor 2Scientific Reports, 2013
- Regulation of PI-3-Kinase and Akt Signaling in T Lymphocytes and Other Cells by TNFR Family MoleculesFrontiers in Immunology, 2013
- TNF-α and TGF-β Counter-Regulate PD-L1 Expression on Monocytes in Systemic Lupus ErythematosusScientific Reports, 2012
- Targeting Regulatory T Cells in CancerCancer Research, 2011
- TNFR1 and TNFR2 regulate the extrinsic apoptotic pathway in myeloma cells by multiple mechanismsCell Death & Disease, 2011
- Acquisition of regulatory function by human CD8+ T cells treated with anti‐CD3 antibody requires TNFEuropean Journal of Immunology, 2010
- Transmembrane TNF- : structure, function and interaction with anti-TNF agentsRheumatology, 2010
- Membrane Tumor Necrosis Factor (TNF) Induces p100 Processing via TNF Receptor-2 (TNFR2)Journal of Biological Chemistry, 2010
- T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTORProceedings of the National Academy of Sciences, 2008
- Tumor necrosis factor signalingCell Death & Differentiation, 2003